LivaNova plc (LIVN) Tops Q3 EPS by 3c; Appoints New CEO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/25/2024
- S&P 500 ends higher as markets weigh rising yields, upbeat corporate results
- Meta Platforms reports softer Q2 revenue guidance on plans to boost spending on AI
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- Equities mixed as investors eye earnings; yen on intervention watch
- ServiceNow (NOW) stock falls as refreshed subscription outlook trails estimates
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Hasbro (HAS) brand strength sees earnings top expectations
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Crude Inventory Declined 6.4 Million Barrels Last Week
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
LivaNova Reports Third Quarter 2016 Results
November 2, 2016 7:46 AM EDTLONDON, Nov. 02, 2016 (GLOBE NEWSWIRE) -- LivaNova PLC (NASDAQ: LIVN)Â (LSE: LIVN) (LivaNova or the Company), a market-leading medical technology and innovation company, today reported results for the third quarter ended September 30, 2016.Â
For the third quarter of 2016, worldwide sales were $295 million, an increase of 3.2 percent on a reported basis and an increase of 2.4 percent on a constant-currency basis1, as compared to the previous year. On a U.S. Generally Accepted Accounting Principles (GAAP) basis, third quarter 2016 loss per share was $0.03. ... More
LivaNova PLC Announces CEO Transition: Damien McDonald to Succeed André-Michel Ballester
November 2, 2016 6:30 AM EDTLONDON, Nov. 02, 2016 (GLOBE NEWSWIRE) -- LivaNova PLC (NASDAQ: LIVN) (LSE: LIVN) (LivaNova or the Company), a market-leading medical technology and innovation company, today named Damien McDonald as the companys new Chief Executive Officer (CEO) and board member, effective January 1, 2017. McDonald currently serves as LivaNovas Chief Operating Officer, and will succeed André-Michel Ballester, who will resign effective December 31, 2016.
Ballester served as CEO of Sorin S.p.A. (Sorin) from 2007 to 2015, prior to the October 2015 merger of Sorin and Cyberonics, Inc. (Cyberonics) to create... More
